129 related articles for article (PubMed ID: 12644732)
1. Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study.
Soyka M; Aichmüller C; v Bardeleben U; Beneke M; Glaser T; Hornung-Knobel S; Wegner U
Eur Addict Res; 2003 Apr; 9(2):65-72. PubMed ID: 12644732
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with flupenthixol decanoate of a patient with both schizophrenia and alcoholism.
Soyka M; Sand P
Pharmacopsychiatry; 1995 Mar; 28(2):64-5. PubMed ID: 7624388
[TBL] [Abstract][Full Text] [Related]
3. Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Chanpattana W; Chakrabhand ML; Sackeim HA; Kitaroonchai W; Kongsakon R; Techakasem P; Buppanharun W; Tuntirungsee Y; Kirdcharoen N
J ECT; 1999 Sep; 15(3):178-92. PubMed ID: 10492856
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Wobrock T; D'Amelio R; Falkai P
Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
[TBL] [Abstract][Full Text] [Related]
5. Differential attrition rates in alcohol abusing and nonabusing schizophrenic inpatients: a methodological note.
Searles JS; Alterman AI
Alcohol Clin Exp Res; 1992 Aug; 16(4):705-7. PubMed ID: 1530133
[TBL] [Abstract][Full Text] [Related]
6. Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence.
Soyka M; De Vry J
Eur Neuropsychopharmacol; 2000 Sep; 10(5):325-32. PubMed ID: 10974602
[TBL] [Abstract][Full Text] [Related]
7. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Soni SD; Sampath G; Shah A; Krska J
Acta Psychiatr Scand; 1992 May; 85(5):354-9. PubMed ID: 1351333
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.
Wobrock T; Soyka M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1375-85. PubMed ID: 18394768
[TBL] [Abstract][Full Text] [Related]
9. Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study.
Levin FR; Evans SM; Coomaraswammy S; Collins ED; Regent N; Kleber HD
Am J Drug Alcohol Abuse; 1998 Aug; 24(3):343-60. PubMed ID: 9741939
[TBL] [Abstract][Full Text] [Related]
10. Short-term effect of combined ECT and neuroleptic therapy in treatment-resistant schizophrenia.
Chanpattana W; Chakrabhand ML; Kongsakon R; Techakasem P; Buppanharun W
J ECT; 1999 Jun; 15(2):129-39. PubMed ID: 10378152
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
San L; Arranz B; Martinez-Raga J
Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
[TBL] [Abstract][Full Text] [Related]
12. Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status.
Chouljian TL; Shumway M; Balancio E; Dwyer EV; Surber R; Jacobs M
Ann Clin Psychiatry; 1995 Mar; 7(1):19-24. PubMed ID: 8541933
[TBL] [Abstract][Full Text] [Related]
13. [Alcohol consumption and its significance in therapeutic residences for psychiatric patients].
Bullenkamp J; Voges B
Psychiatr Prax; 1994 Sep; 21(5):179-83. PubMed ID: 7972559
[TBL] [Abstract][Full Text] [Related]
14. Influence of alcoholism on the prognosis of schizophrenic patients.
Kozarić-Kovacić D; Folnegović-Smalc V; Folnegović Z; Maruĭć A
J Stud Alcohol; 1995 Nov; 56(6):622-7. PubMed ID: 8558893
[TBL] [Abstract][Full Text] [Related]
15. Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
Kalyoncu A; Mirsal H; Pektas O; Unsalan N; Tan D; Beyazyürek M
J Psychopharmacol; 2005 May; 19(3):301-5. PubMed ID: 15888516
[TBL] [Abstract][Full Text] [Related]
16. [Schizophrenia and substance dependence].
Uchtenhagen A
Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
[TBL] [Abstract][Full Text] [Related]
17. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].
Lambert M; Haasen C; Mass R; Krausz M
Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658
[TBL] [Abstract][Full Text] [Related]
18. Dyskinesia and withdrawal from alcohol.
Halliday J
Br J Psychiatry; 1994 Sep; 165(3):409-10. PubMed ID: 7994523
[No Abstract] [Full Text] [Related]
19. Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study.
Wiesbeck GA; Weijers HG; Lesch OM; Glaser T; Toennes PJ; Boening J
Alcohol Alcohol; 2001; 36(4):329-34. PubMed ID: 11468134
[TBL] [Abstract][Full Text] [Related]
20. Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia.
Sullivan EV; Rosenbloom MJ; Serventi KL; Deshmukh A; Pfefferbaum A
Am J Psychiatry; 2003 Jun; 160(6):1110-6. PubMed ID: 12777269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
